|
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016 open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15 |
Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter
Copyright Infringement Claims
Indexing Partner
|
Published Paper Details
|
|
| Paper Title: | A REVIEW ON PULMONARY DRUG DELIVERY SYSTEM FOR NONOTHERAPEUTICS (NANOTECHNOLOGY) |
| Authors Name: | Disha .D Ade , Mayuri .S Avdhut , Dipak.U Adhav , Dipali .D Bhalerao , Javed A. Bagwan |
| Unique Id: | IJSDR2312055 |
| Published In: | Volume 8 Issue 12, December-2023 |
| Abstract: | Drug delivery to the lungs is an innovative and challenging area of pharmaceutical research. Pulmonary drug delivery is relatively complex because the respiratory tract has evolved defence mechanisms to keep inhaled drug particles out of the lungs and to remove or inactivate them once deposited. Pulmonary drug delivery is a route of administration in which patients use an inhaler to inhale their medications and drugs are absorbed into the bloodstream via the lung mucous membrane. It is primarily used to treat conditions of the airways, delivering locally acting drugs directly to their site of action. Pulmonary drug delivery system refers to a device, technology or formulation of a drug meant for infusion into the body via the pulmonary route. Nano carriers offer advantages such as enhanced drug solubility, prolonged release, and targeted delivery to specific cells. this review explores the current state of nasopulmonary drug delivery, Nanomaterial’s have the potential to sustained drug delivery, long time action ,less side effects, and improved patient compliance. Nano carrier systems is being designed for efficient delivery of drugs by researchers nowadays. Nanomaterial’s undergoes easy adsorption in the larger surface area of alveoli. Some of them include dendrimers , liposomes, magnetic nanoparticles, solid lipid nanoparticles, etc in pulmonary system. Nanomaterial have the potential to sustained drug delivery, long time action, less side effects and improved patient compliance. Nanocatgerapeutics offer advantages such as enhanced drug solubility, and targeted delivery to the cells. |
| Keywords: | Pulmonary drug delivery , lung, nanocarriers ,TB , COPD. |
| Cite Article: | "A REVIEW ON PULMONARY DRUG DELIVERY SYSTEM FOR NONOTHERAPEUTICS (NANOTECHNOLOGY)", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 12, page no.402 - 409, December-2023, Available :http://www.ijsdr.org/papers/IJSDR2312055.pdf |
| Downloads: | 000338720 |
| Publication Details: | Published Paper ID: IJSDR2312055 Registration ID:209555 Published In: Volume 8 Issue 12, December-2023 DOI (Digital Object Identifier): Page No: 402 - 409 Publisher: IJSDR | www.ijsdr.org ISSN Number: 2455-2631 |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijsdr.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
Track Paper
Important Links
Conference Proposal
ISSN
 |
 |
DOI (A digital object identifier)
  Providing A digital object identifier by DOI How to GET DOI and Hard Copy Related |
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
 |
 |
 |
Social Media
Indexing Partner |
|||
| Copyright © 2024 - All Rights Reserved - IJSDR | |||
Facebook Twitter Instagram LinkedIn